SEC Form 4 research
| Issuer | Revolution Medicines, Inc. |
|---|---|
| Tickers | RVMD |
| Reporting owners | 50 |
| Officers and directors | 15 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-29 | Sandler Alan B. | S | 301 | $204.72 | Not reported |
| 2026-10-01 | 2026-09-29 | Sandler Alan B. | S | 1,199 | $203.91 | Not reported |
| 2026-10-01 | 2026-09-29 | Sandler Alan B. | S | 1,000 | $202.81 | Not reported |
| 2026-10-01 | 2026-09-29 | Sandler Alan B. | S | 1,609 | $201.72 | Not reported |
| 2026-10-01 | 2026-09-29 | Sandler Alan B. | S | 2,200 | $200.82 | Not reported |
| 2026-09-29 | 2026-09-25 | Cislini Jeff | S | 765 | $207.32 | Not reported |
| 2026-09-28 | 2026-09-25 | Mancini Anthony | S | 3,121 | $200.54 | Not reported |
| 2026-09-28 | 2026-09-24 | Mancini Anthony | S | 587 | $200 | Not reported |
| 2026-09-24 | 2026-09-22 | ANDERSON ELIZABETH M | S | 100 | $195.15 | Not reported |
| 2026-09-24 | 2026-09-22 | ANDERSON ELIZABETH M | S | 1,500 | $194.59 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.